BMJ4d
Mental disorders and cardiovascular disease: what should we be looking out for?
Correspondence to Dr Matthias Michal, Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz 55131, Germany; ...
BMJ5d
Percutaneous coronary intervention for stable coronary artery disease
The adverse consequences of stable coronary artery disease (CAD) are death, myocardial infarction (MI) and angina. Trials in stable CAD show that percutaneous coronary intervention (PCI) does not ...
BMJ8d
Atrial arrhythmia and heart failure in adult patients with congenital heart disease: a retrospective cohort study
Background Atrial arrhythmias (AA) and heart failure (HF) are major causes of hospitalisation in adult congenital heart disease (ACHD). This study aimed to evaluate the temporal relationship between ...
BMJ8d
Optimising management of moderate secondary mitral regurgitation: insights into pharmacological and interventional approaches
Secondary mitral regurgitation (SMR) is a complex and evolving challenge in the landscape of heart failure (HF) management. Although significant secondary MR has been widely recognised for its adverse ...
BMJ9d
Granulocyte colony-stimulating factor for stem cell mobilisation in acute myocardial infarction: a randomised controlled trial
Background To determine whether granulocyte colony-stimulating factor (G-CSF) improves clinical outcomes after large ST-elevation myocardial infarction (STEMI) when administered early in patients with ...
BMJ13d
Change in renal function associated with drug treatment in heart failure: national guidance
Inhibitors of the renin–angiotensin–aldosterone (RAAS) system are cornerstones of the management of patients with heart failure with reduced left ventricular ejection fraction (HFrEF). However, RAAS ...
BMJ13d
Addition of cystatin C predicts cardiovascular death better than creatinine in intensive care
Objective Decreased kidney function increases cardiovascular risk and predicts poor survival. Estimated glomerular filtration rate (eGFR) by creatinine may theoretically be less accurate in the ...
BMJ14d
Association of innate versus specific immunity with heart failure incidence: a prospective study
Background Immune disorders are key heart failure (HF) triggers, but little is known about whether the status of immunity ...
BMJ16d
Evolving use and clinical outcomes of coronary intravascular lithotripsy: insights from an international, multicentre registry
Background Intravascular lithotripsy (IVL) is increasingly used for treatment of coronary artery calcification. This study aimed to evaluate contemporary utilisation patterns, safety and efficacy of ...
BMJ17d
Brugada syndrome: update and future perspectives
Correspondence to Dr Carol Ann Remme, Amsterdam UMC Location AMC, 1105 AZ Amsterdam, The Netherlands; c.a.remme{at}amsterdamumc.nl Brugada syndrome (BrS) is an inherited cardiac disorder, ...
BMJ29d
Table of contents
72 Needing ‘bail-out’ therapy to stabilise outpatient worsening heart failure highlights a high-risk cohort for recurrent instability (16 October, 2024) Free ...